Clinical Trial Search
Clinical Trials: RG1507
-
BO19373
A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.
Completed -
NO21160
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).
Completed -
NO21161
A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer
Completed -
NO21200
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Completed -
NO22068
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors
Completed -
NP22002
A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer
Completed -
NO21157
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.
Active, not recruiting -
NO21746
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) having Received Tarceva Monotherapy.
Active, not recruiting -
NO21884
A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors
Active, not recruiting